Diagnostic Testing for Equine Endocrine Diseases : Confirmation Versus Confusion - 04/07/19
Résumé |
Despite there being only 2 common endocrine diseases in horses, pituitary pars intermedia dysfunction (PPID) and equine metabolic syndrome (EMS), diagnosis is still confusing. Failing to consider horse factors and treating based on laboratory results only have caused many animals to receive lifelong drug treatment unnecessarily. Increased plasma ACTH, baseline or TRH stimulated, supports a diagnosis of PPID; however, breed, age, thriftiness, illness, coat color, geography, diet, and season also affect ACTH concentration. Insulin dysregulation, the hallmark of EMS, can result from insulin resistance or excessive postprandial insulin release. Each requires a different diagnostic test to reach a diagnosis.
Le texte complet de cet article est disponible en PDF.Keywords : Equine pituitary pars intermedia dysfunction, Equine metabolic syndrome, ACTH, Insulin
Plan
| Disclosure Statement: Dr D. McFarlane has no conflict of interest. She has participated in the Equine Endocrinology Group that provides recommendations on diagnostic testing for PPID that is distributed by Boehringer Ingelheim (BI) in marketing handouts and in the Equine Endocrine Summit (a small group scientific meeting), both of which have been supported by BI. |
Vol 35 - N° 2
P. 327-338 - août 2019 Retour au numéro
Article précédent
- Treatment Options for Melanoma of Gray Horses
- Robert J. MacKay
- Exercise-induced Pulmonary Hemorrhage : Is It Important and Can It Be Prevented?
- Eleanor J. Crispe, Guy D. Lester
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?